Two more domestic Covid19 vaccines approved by China
The vaccines made by CanSino Biologics and a unit of Sinopharm were given conditional approvals after they were found protective against Covid-19, said the National Medical Products Administration.
Sinopharm affiliate Wuhan Institute Of Biological Products says its vaccine has an efficacy rate of 72.51 percent, while the overall efficacy for CanSino’s stands at 65.28 percent after 28 days.
On Thursday, the Chinese drug agency said it would require both licence holders to “continue carrying out relevant research, complete the conditional requirements, and submit follow-up research results in a timely manner”.
So far, China has not approved COVID-19 vaccines developed by Western drug makers. The four approved Chinese vaccines can be stored at normal freezer temperatures – a potential selling point in less affluent countries that might have difficulty deploying vaccines from Pfizer and Moderna that require much colder temperatures for longer-term storage.
The three companies have all secured supply deals overseas, and China has donated doses made by Sinopharm’s Beijing unit to numerous countries. China is exporting vaccines to 27 countries and providing free doses to 53 countries, a foreign ministry spokesman said on Tuesday.